Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
My thoughts also. Although could rise slowly to 1ish pre submission
What is your conservative opinion on sp in the coming months assuming 1.5 billion shares outstanding?
Until submission -
Submission -
Waiting for regulatory decision -
Drug approval -
Thanks
What is it with you and 375/875??
You would know
We shall see soon enough.
I know you will not respond to this post, just like any other post that hits home. What will you do after submission and approval? Will you shift goal posts to something like, dcvax may work but it will not turn a profit? I mean if you stop posting you will suddenly have an extra 6 hours a day on your hands. Retirement?
You’ll have to change your handle to something like ex-squared or something of that nature.
Thanks I guess ;)
Well stated. It’s too bad you aren’t around anymore.
Ok thanks
When will this finally happen?
Sure you did
Well why are you posting here? You obviously are not long. Are you short? What’s your interest?
Ridiculous. Not even believable. Your post shows what your real interest is.
Nailed it iron Mike!
Hmmmmm
Not really
How exactly are these “excuses” trending? The company has not issued any new guidance. Are you saying that posters on this board represent the company? Do you have any evidence for this or is this just more speculation?
Yeh that makes sense
The main reason I believe it will be approved on its own (the trial did not test it in combination with checkpoints etc.) is it’s amazingly benign side effects profile. Even if it only helps a subset of patients and on average adds “only” 3 months to OS, there is no cost associated with it. This is in contradistinction with other treatments that have a negative side effects profile. At minimum I would expect a conditional approval pending completion of a phase IV trial (which is de facto equivalent to a full approval).
I agree that the potential of dcvax when added to other treatments is insane but unfortunately it would be highly speculative to bank on that in the near future.
The question that I think we need to answer is why are 27 modules being prepared for submission. That seems excessive for one drug in one jurisdiction. I have read the previous theories but they remain speculative.
I agree but it’s important to understand that now a days there rarely are stellar results. Improvements in cancer care are incremental, a few months at most. That’s the reality of where we are.
He never answers this point. He is quite selective how he responds.
You should email jama. They must have missed this.
You should email jama with this important fact.
You should jama. They must have overlooked this.
Thanks for reading my thoughts so accurately. Like I said, you must be a truly gifted specimen.
Haha!!
You are funny I’ll give you that.
Yes I understand what happened, as do other sophisticated investors. You are either naive or perhaps playing dumb to further your trading strategy.
Hopefully you never need an idiot like me to interpret your loved ones scans.
Wow you’re a genius Mikey! I’m sure they hadn’t thought of these issues themselves.
Lol
Can you pm me who he is?
Thanks in advance
Yup. I guess you’re right, everyone is lying.
;)
Aha, 3 years right. Question, do you get paid per post or for drop in sp? How does the pay structure work? I ask because Notacure seems ripe for a similar opportunity.
So sell and leave us some peace and quiet from your incessant nonsense posts.
I disagree. Think about the journal article. We waited and heard nothing until it was published. They didn’t say that the plan to submit in such and such journal. Their silence means nothing, nothing positive and nothing negative. It’s something they now believe in, for better or worse. Submission could happen tomorrow or in a year, we have no idea.
Also no side effects so in terms of risk benefit analysis it’s a no brainer, pun intended.
I’m sure when it goes back you’ll tell us you bought at the bottom. Very convincing.